Telmisartan and Rosuvastatin Tablets 80/10 mg
Telmisartan 80mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Dongwha Pharmaceutical Co., Ltd.
MFDS item code 202001855 · Approved 2020.03.17
This product's status changed to Approval withdrawn on 2024.04.09. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of hypertension, improvement of dyslipidemia, and suppression of arteriosclerosis progression and cardiovascular disease risk
This medication is used for patients who require the simultaneous administration of telmisartan and rosuvastatin. Telmisartan is primarily used to treat essential hypertension and reduce the risk of cardiovascular diseases. It is particularly effective at reducing the risk of myocardial infarction, stroke, and death due to cardiovascular diseases in high-risk patients. Rosuvastatin is used to treat hypercholesterolemia and dyslipidemia that are not controlled by diet, reducing LDL cholesterol and delaying the progression of atherosclerosis. It also helps reduce the risk of cardiovascular diseases and strokes, including myocardial infarction. Therefore, this medication is used to effectively reduce cardiovascular disease risk in patients with concomitant hypertension and dyslipidemia.
This medicine is administered to adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan and rosuvastatin components. ○ Telmisartan 1. Essential hypertension Adults: The recommended dose is 40 mg of telmisartan orally once daily. Depending on the patient, 20 mg once daily may be effective. If necessary, the dose may be increased to 80 mg once daily. 2. Reduction of cardiovascular risk Adults: The recommended dose is 80 mg of this medicine orally once daily. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. 3. Patients with hepatic impairment Use with caution in patients with mild to moderate hepatic impairment, and do not exceed 40 mg once daily. ○ Rosuvastatin calcium 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be appropriately adjusted at intervals of 4 weeks or more according to the LDL cholesterol level, treatment goals, and the patient's response, and may be increased up to a maximum of 20 milligrams once daily. 2. Elderly patients: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary for patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40 milligrams dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40 milligrams dose of this medicine is contraindicated in some of these patients.
This medication can cause severe harm, especially to the fetus and newborn during pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. It should not be used in patients with hypersensitivity to this medication, pregnant or breastfeeding women, or women of childbearing age who are not utilizing appropriate contraception. This medication is not suitable for patients with severe liver dysfunction or problems with bile excretion. Patients with a history of myopathy or hereditary angioedema should also avoid using this medication. It is prohibited for patients with severe renal impairment or those taking certain immunosuppressants. This medication contains lactose and should not be given to patients with lactose intolerance. Elderly patients, those with hyperkalemia, and patients with mild liver dysfunction should use this medication with caution and undergo regular tests of liver enzymes and kidney function. If symptoms such as muscle pain, weakness, or cramps occur, consult a physician immediately, and blood tests may be required to check for muscle damage if necessary. The risk of side effects may increase when this medication is combined with other antihypertensives or certain lipid-lowering agents, hence it should be taken according to the physician's instructions. Abnormal symptoms such as liver dysfunction, allergic reactions, hypotension, and worsening kidney function may occur, so patients should inform their healthcare provider immediately if any symptoms arise. This medication may cause dizziness or drowsiness while driving or operating machinery, so caution is advised. Keep out of reach of children and do not transfer to another container for safety.
Headache, orthostatic dizziness, sleep paralysis, blood pressure elevation, blood pressure decrease, hypotension, ALT elevation, dysuria, rhinitis, discomfort in the oropharynx, pulmonary disease, unspecified gastrointestinal disease, benign gastrointestinal neoplasm, hemorrhoids, skeletal pain, osteoporosis, sensory impairment, movement disorders, atherosclerosis, increased urination, tinnitus, hearing loss, halitosis, fatty liver, upper respiratory tract infection, urinary tract infection, sepsis, anemia, thrombocytopenia, eosinophilia, hypersensitivity, anaphylactic reaction, hyperkalemia, hypoglycemia, depression, insomnia, anxiety, syncope, visual disturbances, dizziness, bradycardia, tachycardia, dyspnea, abdominal pain, diarrhea, dyspepsia, abdominal bloating, vomiting, abdominal discomfort, dry mouth, liver function impairment, liver damage, increased sweating, itching, rash, erythema, angioedema, drug rash, toxic skin rash, eczema, hives, myalgia, back pain, muscle cramps, arthralgia, limb pain, tendon pain, acute renal failure, chest pain, weakness, influenza-like illness, increased serum creatinine, increased serum uric acid, increased liver enzymes, elevated serum CK, decreased hemoglobin, facial spasms, sensory abnormalities, paralysis, cough, hyperventilation, pneumonia, flushing, erectile dysfunction, loss of appetite, arrhythmia, weakness, edema, decreased libido, facial edema, alopecia, conjunctivitis, tinnitus, petechial hemorrhage, hypersensitivity reaction including angioedema, diabetes, headache, dizziness, constipation, nausea, pancreatitis, pruritus, rash, hives, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, diarrhea, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, drug reaction syndrome with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, severe muscle weakness, ocular myasthenia, palpitations, fatigue, nausea, insufficient effect
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air or moisture ingress, and it is recommended to keep it at room temperature between 1°C and 30°C. Storing it this way will help maintain the medication's efficacy for a longer period.
Bright blue oval film-coated tablets
30 tablets/box [(10 tablets/PTP*3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Telmisartan 80mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Dongwha Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Yuhan Corporation.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Yuhannanghang Co., Ltd.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Yuhan Corporation Co., Ltd.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 40mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.